Tenecteplase administered up to 24 hours after stroke onset improved functional outcomes in patients with large-vessel occlusion and salvageable brain tissue who lacked access to immediate thrombectomy.

A phase 3 clinical trial of buntanetap in early Parkinson’s disease patients demonstrated improvements in motor and cognitive functions, particularly in those with longer disease duration and postural instability.

A recent study involving 230 untreated relapsing-remitting MS patients found that vitamin D levels below 20 ng/mL were associated with a more than twofold increase in the risk of disease activity. This finding emphasizes the potential importance of vitamin D monitoring and management in MS patient care.

LANS presents with memory symptoms that mimic Alzheimer’s disease, but brain imaging and biomarkers indicate a different underlying condition, potentially leading to more accurate diagnoses and prognoses for older adults with cognitive decline.

Proper management of benzodiazepine withdrawal requires individualized care plans and close patient monitoring to mitigate potentially severe health risks.

Lion’s mane mushroom stimulates nerve growth factor production, potentially supporting neuron growth and survival, with implications for cognitive health and neurological disorders.